Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
AZTR is expected to report earnings to fall 67.16% to -21 cents per share on March 13
Q4'25
Est.
$-0.22
Q3'25
Missed
by $0.46
Q4'24
Beat
by $0.20
The last earnings report on November 12 showed earnings per share of -67 cents, missing the estimate of -20 cents. With 440.59K shares outstanding, the current market capitalization sits at 3.37M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. AZTR showed earnings on November 12, 2025. You can read more about the earnings report here.